Crossmark

Biomarker-oriented chemo-immunotherapy for advanced gastric cancer

Published Online: 2024-04-22

Published Print: 2024-07

Authors

Kono, Koji https://orcid.org/0000-0003-0106-2767
Nakajima, Shotaro

Mimura, Kosaku
License Information

Text and Data Mining valid from 2024-04-22

Version of Record valid from 2024-04-22
More Information

Article History

Received: 18 March 2024

Accepted: 1 April 2024

First Online: 22 April 2024

Declarations

:

: Koji Kono has received a speaker honorarium from Ono pharmaceutical company, Bristol Myers Squibb and MSD pharmaceutical company.

Document is current